Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Informatica Inc. (INFA)
Arteris, Inc. (AIP)
Rent The Runway, Inc. (RENT)
Informatica Inc. (NYSE)
Fluence Energy, Inc. (FLNC)
Ensemble Health Partners, Inc. (ENSB)
Lianbio (LIAN)
Candela Medical, Inc. (CDLA)
Globalfoundries, Inc. (GFS)
Solo Brands, Inc. (DTC)
Udemy, Inc. (UDMY)
Hireright Holdings Corporation (HRT)
Airsculpt Technologies, Inc. (AIRS)
Priced IPO
Aris Water Solutions, Inc. (ARIS)
Minerva Surgical, Inc (UTRS)
Xilio Therapeutics, Inc. (XLO)
Enfusion, Inc. (ENFN)
Portillos Inc. (PTLO)
The Vita Coco Company, Inc. (COCO)
P10, Inc. (PX)
Ventyx Biosciences, Inc. (VTYX)
Runway Growth Finance Corp (RWAY)
Context Therapeutics (CNTX)
Stronghold Digital Mining, Inc. (SDIG)
Cyngn (CYN)
Mink Therapeutics, Inc. (INKT)
Paragon 28, Inc. (FNA)
Ihs Holding Limited (IHS)
Gitlab Inc. (GTLB)
Lucid Diagnostics, Inc. (LUCD)
Healthcare Triangle (HCTI)
AvidXchange (AVDX)
Cognition Therapeutics, Inc. (CGTX)
More companies

DA32 Life Science Tech Acquisition (DALS)

Sector - SPAC

Price chart

-2.8%
Return from IPO

Last SPACs News

IPO Profile

About company

They are a newly organized blank check company. While they may pursue an initial business combination target in any business industry or geographic region, they intend to capitalize on their management team’s background and experience to identify promising opportunities in the life sciences sector. In coming together as co-sponsors of DA32, Deerfield Management, ARCH Venture Partners and Section 32 aim to leverage their complementary capabilities and networks in order to acquire, merge with and grow a promising life science technology opportunity. Individually, each of their sponsors brings deep industry expertise and a broad network across the life science technology landscape, including both private and public companies in all stages of development. Collectively, they believe that their sponsors are well positioned to help DA32 successfully identify an attractive company and equip it with the tools and connections needed to accelerate growth and become a successful publicly traded company. By combining the healthcare knowledge and sourcing networks of their sponsors, they intend to execute their strategy to bring forward a meaningful, positive impact on human health. With accelerating advancements in research technology and a boom in healthcare data and biological insights, they believe the time is ripe, and DA32 is strongly positioned to pursue opportunities in the life sciences technology industry.
Industry
Blank Checks
CEO CFO
-
Employees Founded
2 2021

Contacts

Address: 345 Park Avenue South, 12th Floor New York, Ny 10010, Us

Telephone: (212) 551-1600

Web page:

IPO information

First Trade Date 7/28/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 20
Shares Revised (MM) 20
Expected offer amount (MM) $200
Realized offer amount(MM) $200

Financial Data (last reporting year)

Market Cap (MM) $256.5
Revenues (MM) $0
Net Income (Loss) (MM) $0

Voting

What do you think will happen with the DALS share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Underwriters
JP Morgan/ Cowen
CO-Managers